Related Experiment Video
Updated: Jul 4, 2026

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites
Published on: March 22, 2016
The incorporation of APOBEC3 proteins into murine leukemia viruses
1Department of Virology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, Beijing 100050, China.
Abstract:
APOBEC3 proteins represent a group of potent intrinsic inhibitors of retroviral replication. Murine APOBEC3 (mA3) is able to inhibit HIV-1, whereas it is inactive against Moloney murine leukemia virus (MLV). In this work, we present evidence showing that mA3, compared to hA3G, is incorporated inefficiently into MLV, while the abilities of mA3 and hA3G to be packaged into HIV-1 are similar. The nucleocapsid (NC) domain of HIV-1 is capable of facilitating the interaction of mA3 with HIV-1 Gag, and thereby the incorporation of mA3 into HIV-1. Swapping studies of the NC domains in HIV-1 and MLV indicate that MLV NC domain is responsible for viral exclusion of mA3, due to its inability to facilitate the mA3/Gag interaction. The interaction between mA3 and HIV-1 Gag is mediated by the linker region between two zinc coordination motifs in mA3, similar to what has been found for the incorporation of hA3G into both HIV-1 and MLV. These results suggest that the interaction between NC domains and the linker regions might represent a common mechanism for viral incorporation of APOBEC3 proteins, and the inefficient incorporation of endogenous mA3 appears to be a strategy by which MLV escapes the inhibitory effect of mA3.
Insights
Murine APOBEC3 (mA3) is less incorporated into Moloney murine leukemia virus (MLV) than human APOBEC3G (hA3G) due to MLV’s nucleocapsid domain. This inefficient incorporation allows MLV to evade mA3 antiviral activity.
Area of Science:
- Retroviral replication
- Innate immunity
- Antiviral mechanisms
Background:
- APOBEC3 proteins are crucial intrinsic antiviral factors that restrict retroviral replication.
- Murine APOBEC3 (mA3) inhibits HIV-1 but not Moloney murine leukemia virus (MLV).
- The differential activity suggests variations in APOBEC3 incorporation into different retroviruses.
Purpose of the Study:
- To investigate the mechanisms underlying the differential incorporation of mA3 into HIV-1 and MLV.
- To identify viral factors responsible for mA3 exclusion from MLV particles.
- To elucidate the role of APOBEC3 protein domains and viral protein interactions in viral packaging.
Main Methods:
- Comparative analysis of mA3 and hA3G incorporation into HIV-1 and MLV virions.
- Site-directed mutagenesis and domain swapping studies involving the nucleocapsid (NC) domains of HIV-1 and MLV.
- Investigation of interactions between mA3 and viral Gag proteins.
Main Results:
- mA3 is incorporated less efficiently into MLV compared to HIV-1, while mA3 and hA3G incorporation into HIV-1 is similar.
- The MLV nucleocapsid (NC) domain, unlike the HIV-1 NC domain, fails to facilitate mA3/Gag interaction, leading to mA3 exclusion from MLV.
- The linker region between zinc coordination motifs in mA3 mediates interaction with HIV-1 Gag, similar to hA3G.
Conclusions:
- The interaction between viral NC domains and APOBEC3 linker regions is a key mechanism for viral incorporation of these antiviral proteins.
- MLV's inability to facilitate mA3/Gag interaction via its NC domain is responsible for excluding mA3.
- Inefficient mA3 incorporation is a viral strategy for MLV to escape the inhibitory effects of endogenous mA3.
Related Concept Videos
Leaky Scanning
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Intralumenal Vesicles and Multivesicular Bodies

